SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-011429
Filing Date
2022-03-23
Accepted
2022-03-22 21:35:51
Documents
14
Period of Report
2022-03-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K (KOWALSKI AGREEMENTS) srra-8k_20220322.htm   iXBRL 8-K 49526
2 EX-10.1 srra-ex101_9.htm EX-10.1 116793
3 EX-10.2 srra-ex102_8.htm EX-10.2 80687
  Complete submission text file 0001564590-22-011429.txt   412694

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srra-20220322.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220322_lab.xml EX-101.LAB 18672
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220322_pre.xml EX-101.PRE 11133
8 EXTRACTED XBRL INSTANCE DOCUMENT srra-8k_20220322_htm.xml XML 3405
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 22761425
SIC: 2834 Pharmaceutical Preparations